166 related articles for article (PubMed ID: 38063232)
1. Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis.
Wang YY; Cheng KH; Hung AC; Lo S; Chen PY; Wu YC; Hou MF; Yuan SF
Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063232
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
Hallajian Z; Mahjoubi F; Nafissi N
Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.
Mirza S; Rakha EA; Alshareeda A; Mohibi S; Zhao X; Katafiasz BJ; Wang J; Gurumurthy CB; Bele A; Ellis IO; Green AR; Band H; Band V
Breast Cancer Res Treat; 2013 Feb; 137(3):721-31. PubMed ID: 23288344
[TBL] [Abstract][Full Text] [Related]
6. RAD51 Is Implicated in DNA Damage, Chemoresistance and Immune Dysregulation in Solid Tumors.
Liao C; Talluri S; Zhao J; Mu S; Kumar S; Shi J; Buon L; Munshi NC; Shammas MA
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428789
[TBL] [Abstract][Full Text] [Related]
7. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.
Jia Y; Song Y; Dong G; Hao C; Zhao W; Li S; Tong Z
Sci Rep; 2019 Sep; 9(1):12939. PubMed ID: 31506496
[TBL] [Abstract][Full Text] [Related]
9. Rad51 supports triple negative breast cancer metastasis.
Wiegmans AP; Al-Ejeh F; Chee N; Yap PY; Gorski JJ; Da Silva L; Bolderson E; Chenevix-Trench G; Anderson R; Simpson PT; Lakhani SR; Khanna KK
Oncotarget; 2014 May; 5(10):3261-72. PubMed ID: 24811120
[TBL] [Abstract][Full Text] [Related]
10. Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer.
Toh MR; Low CE; Chong ST; Chan SH; Ishak NDB; Courtney E; Kolinjivadi AM; Rodrigue A; Masson JY; Ngeow J
Fam Cancer; 2020 Apr; 19(2):123-131. PubMed ID: 32048105
[TBL] [Abstract][Full Text] [Related]
11. DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.
Woditschka S; Evans L; Duchnowska R; Reed LT; Palmieri D; Qian Y; Badve S; Sledge G; Gril B; Aladjem MI; Fu H; Flores NM; Gökmen-Polar Y; Biernat W; Szutowicz-Zielińska E; Mandat T; Trojanowski T; Och W; Czartoryska-Arlukowicz B; Jassem J; Mitchell JB; Steeg PS
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24948741
[TBL] [Abstract][Full Text] [Related]
12. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.
Gasparini P; Lovat F; Fassan M; Casadei L; Cascione L; Jacob NK; Carasi S; Palmieri D; Costinean S; Shapiro CL; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4536-41. PubMed ID: 24616504
[TBL] [Abstract][Full Text] [Related]
13. High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer.
Wu R; Patel A; Tokumaru Y; Asaoka M; Oshi M; Yan L; Ishikawa T; Takabe K
Breast Cancer Res Treat; 2022 May; 193(1):49-63. PubMed ID: 35249172
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.
Kurozumi S; Alsaeed S; Orah N; Miligy IM; Joseph C; Aljohani A; Toss MS; Fujii T; Shirabe K; Green AR; Aleskandarany MA; Rakha EA
Breast Cancer Res Treat; 2020 Feb; 179(3):557-564. PubMed ID: 31707510
[TBL] [Abstract][Full Text] [Related]
15. High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.
Barbano R; Copetti M; Perrone G; Pazienza V; Muscarella LA; Balsamo T; Storlazzi CT; Ripoli M; Rinaldi M; Valori VM; Latiano TP; Maiello E; Stanziale P; Carella M; Mangia A; Pellegrini F; Bisceglia M; Muda AO; Altomare V; Murgo R; Fazio VM; Parrella P
Int J Cancer; 2011 Aug; 129(3):536-45. PubMed ID: 21064098
[TBL] [Abstract][Full Text] [Related]
16. Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C.
Gildemeister OS; Sage JM; Knight KL
J Biol Chem; 2009 Nov; 284(46):31945-52. PubMed ID: 19783859
[TBL] [Abstract][Full Text] [Related]
17. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer.
Zhang X; Liu G; Qiu J; Zhang N; Ding J; Hua K
Sci Rep; 2017 Jun; 7(1):4469. PubMed ID: 28667302
[TBL] [Abstract][Full Text] [Related]
18. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
Alshareeda AT; Negm OH; Green AR; Nolan CC; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2015 Jun; 112(12):1929-37. PubMed ID: 25989275
[TBL] [Abstract][Full Text] [Related]
19. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.
Mani C; Jonnalagadda S; Lingareddy J; Awasthi S; Gmeiner WH; Palle K
Breast Cancer Res; 2019 Sep; 21(1):104. PubMed ID: 31492187
[TBL] [Abstract][Full Text] [Related]
20. XRCC3 and RAD51 expression are associated with clinical factors in breast cancer.
Hu J; Wang N; Wang YJ
PLoS One; 2013; 8(8):e72104. PubMed ID: 23977219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
